|Articles|July 11, 2018

Dealing with state regulation of the pharma supply chain

A patchwork of regulations challenges manufacturers and distributors in the US

Click here to download FRR's 2018 Definitive Guide to State Licensing

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Subscribe

Related Content

CMS Could Make Drug Price Negotiations Permanent - What it Means for Pharma

ByStephen Appezzato

June 16th 2026

A close up of an audio sound mixer displays a digital heartbeat pulse and medical ECG graph line on a computer technology monitor for health data illustration. | © Hena Akter - stock.adobe.com (1974661874)

How Behavioral and Engagement Insights Improve Persistence in Patient Support Programs

ByIsabelle Amick,Jack McFeely

June 16th 2026

High angle satellite view of the Strait of Hormuz showing the strategic maritime chokepoint between Iran and Oman for global trade and logistics | © ink drop - stock.adobe.com (1957527497)

FAQ: Strait of Hormuz Reopening — What It Means for Pharma Supply Chains

ByStephen Appezzato

June 15th 2026

Will Shrank: The Trillion-Dollar Question Facing CGT Access

ByWill Shrank, MD,Stephen Appezzato

June 15th 2026

3d rendered image of a large collections of glucagon like peptide 1 or GLP-1 injection pens. | peter hansen - stock.adobe.com (1974768137)

Why Some Employers Are Scaling Back GLP-1 Coverage in 2027

ByStephen Appezzato

June 11th 2026

Dealing with state regulation of the pharma supply chain

Related Content

CMS Could Make Drug Price Negotiations Permanent - What it Means for Pharma

How Behavioral and Engagement Insights Improve Persistence in Patient Support Programs

FAQ: Strait of Hormuz Reopening — What It Means for Pharma Supply Chains

Will Shrank: The Trillion-Dollar Question Facing CGT Access

Why Some Employers Are Scaling Back GLP-1 Coverage in 2027

Trending on Pharmaceutical Commerce

FAQ: Strait of Hormuz Reopening — What It Means for Pharma Supply Chains

Will Shrank: The Trillion-Dollar Question Facing CGT Access

CMS Could Make Drug Price Negotiations Permanent - What it Means for Pharma

How Behavioral and Engagement Insights Improve Persistence in Patient Support Programs